Disease Progression on PROs in Patients With aNSCLC With PD-L1 ≥50% Receiving Cemiplimab vs Chemotherapy: EMPOWER-Lung 1

GÜMÜŞ M., Kilickap S., Sezer A., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., ...More

JOURNAL OF THORACIC ONCOLOGY, no.11, 2023 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Publication Date: 2023
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
  • Istanbul University-Cerrahpasa Affiliated: No